{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T19:29:32Z","timestamp":1791142172466,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2015,1,23]],"date-time":"2015-01-23T00:00:00Z","timestamp":1421971200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1038\/npp.2015.27","type":"journal-article","created":{"date-parts":[[2015,1,23]],"date-time":"2015-01-23T11:54:11Z","timestamp":1422014051000},"page":"2059-2065","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["A Double-Blind, Placebo-Controlled Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single, Escalating Oral Doses of JDTic"],"prefix":"10.1038","volume":"40","author":[{"given":"Jeffrey J","family":"Buda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F I","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas R","family":"Kosten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Swearingen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradford B","family":"Walters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,1,23]]},"reference":[{"key":"BFnpp201527_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/cs0850001","volume":"85","author":"A Ationu","year":"1993","unstructured":"Ationu A, Sorensen K, Whitehead B, Singer D, Carter N (1993). Ventricular expression and circulating levels of immunoreactive dynorphin in heart transplant recipients. Clin Sci (Lond) 85: 1\u20134.","journal-title":"Clin Sci (Lond)"},{"key":"BFnpp201527_CR2","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1006\/jmcc.1998.0774","volume":"30","author":"JS Bian","year":"1998","unstructured":"Bian JS, Zhang WM, Xia Q, Wong TM (1998). Phospholipase C inhibitors attenuate arrhythmias induced by kappa-receptor stimulation in the isolated rat heart. J Mol Cell Cardiol 30: 2103\u20132110.","journal-title":"J Mol Cell Cardiol"},{"key":"BFnpp201527_CR3","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/oxfordjournals.eurheartj.a061344","volume":"3","author":"P Bjerregaard","year":"1982","unstructured":"Bjerregaard P (1982). Premature beats in healthy subjects 40-79 years of age. Eur Heart J 3: 493\u2013503.","journal-title":"Eur Heart J"},{"key":"BFnpp201527_CR4","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/S0002-9149(77)80094-5","volume":"39","author":"M Brodsky","year":"1977","unstructured":"Brodsky M, Wu D, Denes P, Kanakis C, Rosen KM (1977). Arrhythmias documented by 24 hour continuous electrocardiographic monitoring in 50 male medical students without apparent heart disease. Am J Cardiol 39: 390\u2013395.","journal-title":"Am J Cardiol"},{"key":"BFnpp201527_CR5","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00213-010-1806-y","volume":"210","author":"MR Bruchas","year":"2010","unstructured":"Bruchas MR, Chavkin C (2010). Kinase cascades and ligand-directed signaling at the kappa opioid receptor. Psychopharmacol 210: 137\u2013147.","journal-title":"Psychopharmacol"},{"key":"BFnpp201527_CR6","doi-asserted-by":"publisher","first-page":"29803","DOI":"10.1074\/jbc.M705540200","volume":"282","author":"MR Bruchas","year":"2007","unstructured":"Bruchas MR, Yang T, Schreiber S, DeFino M, Kwan SC, Li S et al (2007). Long-acting kappa opioid antagonists disrupt receptor signaling and produce noncompetitive effects by activating c-jun N-terminal kinase. J Biol Chem 282: 29803\u201329811.","journal-title":"J Biol Chem"},{"key":"BFnpp201527_CR7","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1021\/jm301783x","volume":"56","author":"FI Carroll","year":"2013","unstructured":"Carroll FI, Carlezon WA Jr (2013). Development of \u03ba opioid receptor antagonists. J Med Chem 56: 2178\u20132195.","journal-title":"J Med Chem"},{"key":"BFnpp201527_CR8","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1002\/cmdc.201402142","volume":"9","author":"FI Carroll","year":"2014","unstructured":"Carroll FI, Dolle RE (2014). The discovery and development of the N-substituted trans-3,4-dimethyl-4-(3\u2019-hydroxyphenyl)piperidine class of pure opioid receptor antagonists. Chem Med Chem 9: 1638\u20131654.","journal-title":"Chem Med Chem"},{"key":"BFnpp201527_CR9","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/S0140-6736(76)90801-1","volume":"1","author":"JM Clarke","year":"1976","unstructured":"Clarke JM, Hamer J, Shelton JR, Taylor S, Venning GR (1976). The rhythm of the normal human heart. Lancet 1: 508\u2013512.","journal-title":"Lancet"},{"key":"BFnpp201527_CR10","doi-asserted-by":"publisher","first-page":"H2091","DOI":"10.1152\/ajpheart.00843.2002","volume":"284","author":"JA Coles Jr","year":"2003","unstructured":"Coles JA Jr, Sigg DC, Iaizzo PA (2003). Role of kappa-opioid receptor activation in pharmacological preconditioning of swine. Am J Physiol Heart Circ Physiol 284: H2091\u2013H2099.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"BFnpp201527_CR11","doi-asserted-by":"publisher","first-page":"36331","DOI":"10.1074\/jbc.M111.272146","volume":"286","author":"K Drosatos","year":"2011","unstructured":"Drosatos K, Drosatos-Tampakaki Z, Khan R, Homma S, Schulze PC, Zannis VI et al (2011). Inhibition of c-jun-N-terminal kinase increases cardiac peroxisome proliferator-activated receptor alpha expression and fatty acid oxidation and prevents lipopolysaccharide-induced heart dysfunction. J Biol Chem 286: 36331\u201336339.","journal-title":"J Biol Chem"},{"key":"BFnpp201527_CR12","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1093\/toxsci\/kfr158","volume":"123","author":"L Guo","year":"2011","unstructured":"Guo L, Abrams RM, Babiarz JE, Cohen JD, Kameoka S, Sanders MJ et al (2011). Estimating the risk of drug-induced proarrhythmia using human induced pluripotent stem cell-derived cardiomyocytes. Toxicol Sci 123: 281\u2013289.","journal-title":"Toxicol Sci"},{"key":"BFnpp201527_CR13","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1213\/01.ane.0000237246.40665.34","volume":"103","author":"MAG Hartlage","year":"2006","unstructured":"Hartlage MAG, Theisen MM, de Oliveira NPM, Aken HV, Fobker M, Weber TP (2006). Kappa-opioid receptor antagonism improves recovery from myocardial stunning in chronically instrumented dogs. Anesth Analg 103: 822\u2013832.","journal-title":"Anesth Analg"},{"key":"BFnpp201527_CR14","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/0002-9149(69)90451-2","volume":"24","author":"LE Hinkle","year":"1969","unstructured":"Hinkle LE, Carver ST, Stevens M (1969). The frequency of asymptomatic disturbances of cardiac rhythm and conduction in middle-aged men. Am J Cardiol 24: 629\u2013650.","journal-title":"Am J Cardiol"},{"key":"BFnpp201527_CR15","unstructured":"Hospira (2007) Package insert for Naloxone Hydrochloride Injection, USP. EN-1367. Hospira: Lake Forest, IL, USA."},{"key":"BFnpp201527_CR16","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.jcfm.2005.01.011","volume":"12","author":"R Hunter","year":"2005","unstructured":"Hunter R (2005). Ventricular tachycardia following naloxone administration in an illicit drug misuse. J Clin Forensic Med 12: 218\u2013219.","journal-title":"J Clin Forensic Med"},{"key":"BFnpp201527_CR17","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s11010-010-0577-4","volume":"345","author":"A Jaiswal","year":"2010","unstructured":"Jaiswal A, Kumar S, Seth S, Dinda AK, Maulik SK (2010). Effect of U50,488H, a \u03ba-opioid receptor agonist on myocardial \u03b1- and \u03b2-myosin heavy chain expression and oxidative stress associated with isoproterenol-induced cardiac hypertrophy in rat. Mol Cell Biochem 345: 213\u2013240.","journal-title":"Mol Cell Biochem"},{"key":"BFnpp201527_CR18","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.arcmed.2008.02.011","volume":"39","author":"L Jin-Cheng","year":"2008","unstructured":"Jin-Cheng L, Wen Y, Zhao Y, Quan-Yu Z, Shu-Miao Z, Hai-Tao G et al (2008). Anti-arrhythmic effects of kappa-opioid receptor and its changes in ischemia and reperfusion. Arch Med Res 39: 483\u2013488.","journal-title":"Arch Med Res"},{"issue":"Suppl 1","key":"BFnpp201527_CR19","doi-asserted-by":"publisher","first-page":"S275","DOI":"10.1111\/j.1540-8159.2005.00073.x","volume":"28","author":"U Lendeckel","year":"2005","unstructured":"Lendeckel U, Muller C, Rocken C, Laube B, Tager M, Huth C et al (2005). Expression of opioid receptor subtypes and their ligands in fibrillating human atria. Pacing Clin Electrophysiol 28 (Suppl 1): S275\u2013S279.","journal-title":"Pacing Clin Electrophysiol"},{"key":"BFnpp201527_CR20","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s10517-007-0046-6","volume":"143","author":"AY Lishmanov","year":"2007","unstructured":"Lishmanov AY, Maslov LN, Lasukova TV, Crawford D, Wong TM (2007). Activation of kappa-opioid receptor as a method for prevention of ischemic and reperfusion arrhythmias: role of protein kinase C and K(ATP) channels. Bull Exp Biol Med 143: 187\u2013190.","journal-title":"Bull Exp Biol Med"},{"key":"BFnpp201527_CR21","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1097\/01.shk.0000183432.17092.34","volume":"24","author":"L Liu","year":"2005","unstructured":"Liu L, Hu D, Pan X, Lu R, Dan F (2005). Subclass opioid receptors associated with the cardiovascular depression after traumatic shock and the antishock effects of its specific receptor antagonists. Shock 24: 470\u2013475.","journal-title":"Shock"},{"key":"BFnpp201527_CR22","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/0143-4179(95)90094-2","volume":"29","author":"F Llobell","year":"1995","unstructured":"Llobell F, Laorden ML (1995). Characterization of the opioid receptor subtypes mediating the negative inotropic effects of DAMGO, DPDPE and U-50,488H in isolated human right atria strips. Neuropeptides 29: 115\u2013119.","journal-title":"Neuropeptides"},{"key":"BFnpp201527_CR23","first-page":"968","volume":"54","author":"SL Lowe","year":"2014","unstructured":"Lowe SL, Wong CJ, Witcher J, Gonzales CR, Dickinson GL, Bell RL et al (2014). Safety, tolerability, and pharmacokinetic evaluation of single- and multiple-ascending doses of a novel kappa opioid receptor antagonist LY2456302 and drug interaction with ethanol in healthy subjects. Pharmacokinetics 54: 968\u2013978.","journal-title":"Pharmacokinetics"},{"key":"BFnpp201527_CR24","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2460\/ajvr.1993.54.02.327","volume":"54","author":"GE Macallum","year":"1993","unstructured":"Macallum GE, Houston BJ (1993). Characterization of cardiac alterations in nonsedated cynomolgus monkeys. Am J Vet Res 54: 327\u2013332.","journal-title":"Am J Vet Res"},{"key":"BFnpp201527_CR25","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1124\/mol.111.074195","volume":"80","author":"EJ Melief","year":"2011","unstructured":"Melief EJ, Miyatake M, Carroll FI, B\u00e9guin C, Carlezon WA, Cohen BM et al (2011). Duration of action of a broad range of selective \u03ba-opioid receptor antagonists is positively correlated with c-jun N-terminal kinase-1 activation. Mol Pharmacol 80: 920\u2013929.","journal-title":"Mol Pharmacol"},{"key":"BFnpp201527_CR26","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.ahj.2010.02.004","volume":"159","author":"SS Min","year":"2010","unstructured":"Min SS, Turner JR, Nada A, DiMino TL, Hynie I, Kleiman R et al (2010). Evaluation of ventricular arrhythmias in early clinical pharmacology trials and potential consequences for later development. Am Heart J 159: 716\u2013729.","journal-title":"Am Heart J"},{"key":"BFnpp201527_CR27","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1097\/00005344-200403000-00012","volume":"43","author":"JN Peart","year":"2004","unstructured":"Peart JN, Gross ER, Gross GJ (2004). Effect of exogenous kappa-opioid receptor activation in rat model of myocardial infarction. J Cardiovasc Pharmacol 43: 410\u2013415.","journal-title":"J Cardiovasc Pharmacol"},{"key":"BFnpp201527_CR28","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.drugalcdep.2012.01.013","volume":"124","author":"J Peng","year":"2012","unstructured":"Peng J, Sarkar S, Chang SL (2012). Opioid receptor expression in human brain and peripheral tissues using absolute quantitative real-time RT-PCR. Drug Alcohol Depend 124: 223\u2013228.","journal-title":"Drug Alcohol Depend"},{"key":"BFnpp201527_CR29","doi-asserted-by":"publisher","first-page":"H669","DOI":"10.1152\/ajpheart.2001.281.2.H669","volume":"281","author":"WG Pyle","year":"2001","unstructured":"Pyle WG, Lester JW, Hofmann PA (2001). Effects of kappa-opioid receptor activation on myocardium. Am J Physiol Heart Circ Physiol 281: H669\u2013H678.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"BFnpp201527_CR30","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s00380-013-0456-5","volume":"29","author":"P Sobanski","year":"2014","unstructured":"Sobanski P, Krajnik M, Shaqura M, Bloch-Boguslawska E, Sch\u00e4fer M, Mousa SA (2014). The presence of mu-, delta-, and kappa-opioid receptors in human heart tissue. Heart Vessels 29: 855\u2013863.","journal-title":"Heart Vessels"},{"key":"BFnpp201527_CR31","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.yjmcc.2013.04.010","volume":"60","author":"H Surendra","year":"2013","unstructured":"Surendra H, Diaz RJ, Harvey K, Tropak M, Callahan J, Hinek A et al (2013). Interaction of \u03b4 and \u03ba opioid receptors with adenosine A1 receptors mediates cardioprotection by remote ischemic preconditioning. J Mol Cell Cardiol 60: 142\u2013150.","journal-title":"J Mol Cell Cardiol"},{"key":"BFnpp201527_CR32","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.1021\/jm030094y","volume":"46","author":"JB Thomas","year":"2003","unstructured":"Thomas JB, Atkinson RN, Vinson NA, Catanzaro JL, Perretta CL, Fix SE et al (2003). Identification of (3R)-7-hydroxy-N-((1S)-1-{[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl}-2-methylpropyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide as a novel and potent and selective opioid \u03ba receptor antagonist. J Med Chem 46: 3127\u20133137.","journal-title":"J Med Chem"},{"key":"BFnpp201527_CR33","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1016\/S0735-1097(99)00095-9","volume":"33","author":"F Tomai","year":"1999","unstructured":"Tomai F, Crea F, Gaspardone A, Versaci F, Ghini AS, Ferri C et al (1999). Effects of naloxone on myocardial ischemic preconditioning in humans. J Am Col Cardiol 33: 1863\u20131869.","journal-title":"J Am Col Cardiol"},{"key":"BFnpp201527_CR34","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1161\/01.RES.70.1.66","volume":"7","author":"C Ventura","year":"1992","unstructured":"Ventura C, Spurgeon H, Lakatta EG, Guarnieri C, Capogrossi MC (1992). Kappa and delta opioid receptor stimulation affects cardiac myocytes function and Ca2+ release from an intracellular pool in myocytes and neurons. Circ Res 7: 66\u201381.","journal-title":"Circ Res"},{"key":"BFnpp201527_CR35","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S0014-2999(03)01974-5","volume":"473","author":"GS Xiao","year":"2003","unstructured":"Xiao GS, Zhou JJ, Cheung YF, Li GR, Wong TM (2003). Effects of U50,488H on transient outward and ultra-rapid delayed rectifier K+ currents in young human atrial myocytes. Eur J Pharmacol 473: 97\u2013103.","journal-title":"Eur J Pharmacol"},{"key":"BFnpp201527_CR36","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1097\/MAJ.0b013e31824ceba7","volume":"345","author":"J Xiu","year":"2013","unstructured":"Xiu J, Liu J, Li H, Fu L, Ding D, Han D (2013). The effects of kappa-opioid receptor on stretch-induced electrophysiological changes in infarcted rat hearts. Am J Med Sci 345: 129\u2013135.","journal-title":"Am J Med Sci"},{"key":"BFnpp201527_CR37","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1006\/jmcc.1999.1014","volume":"31","author":"XC Yu","year":"1999","unstructured":"Yu XC, Wang HX, Pei JM, Wong TM (1999). Anti-arrhythmic effect of kappa-opioid receptor stimulation in the perfused rat heart: involvement of a cAMP-dependent pathway. J Mol Cell Cardiol 31: 1809\u20131819.","journal-title":"J Mol Cell Cardiol"},{"key":"BFnpp201527_CR38","doi-asserted-by":"publisher","first-page":"H1444","DOI":"10.1152\/ajpheart.01279.2006","volume":"294","author":"AJ Zatta","year":"2008","unstructured":"Zatta AJ, Kin H, Yoshishige D, Jiang R, Wang N, Reeves JG et al (2008). Evidence that cardioprotection by postconditioning involves preservation of myocardial opioid content and selective opioid receptor activation. Am J Physiol Heart Circ Physiol 294: H1444\u2013H1451.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"BFnpp201527_CR39","doi-asserted-by":"publisher","first-page":"H40","DOI":"10.1152\/ajpheart.2001.281.1.H40","volume":"281","author":"JJ Zhou","year":"2001","unstructured":"Zhou JJ, Pei JM, Wang GY, Wu S, Wang WP, Cho CH et al (2001). Inducible HSP70 mediates delayed cardioprotection in rat ventricular myocytes. Am J Physiol Heart Circ Physiol 281: H40\u2013H47.","journal-title":"Am J Physiol Heart Circ Physiol"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/npp201527.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp201527","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp201527.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T19:32:40Z","timestamp":1717702360000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/npp201527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,23]]},"references-count":39,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["BFnpp201527"],"URL":"https:\/\/doi.org\/10.1038\/npp.2015.27","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,23]]},"assertion":[{"value":"2 August 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}